Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 27-Mar-24 9:45 AM View:  | Choong Choon Hau 10% Owner | Titan Pharmaceuticals Inc. (TTNP) | 18-Mar-24 | Conversion | 54,132 | -- | -- | 1% 3.75M to 3.8M | |
| 26-Oct-23 4:31 PM View: | McMurdo Matthew Charles Director | Titan Pharmaceuticals Inc. (TTNP) | 25-Oct-23 | Grant | 16,250 | -- | -- | 32% 50.0K to 66.25K | |
| 26-Oct-23 4:33 PM View: | Natan David Director | Titan Pharmaceuticals Inc. (TTNP) | 25-Oct-23 | Grant | 16,250 | -- | -- | 32% 50.0K to 66.25K | |
| 26-Oct-23 4:23 PM View: | Ben-Tzvi Avraham Director | Titan Pharmaceuticals Inc. (TTNP) | 25-Oct-23 | Grant | 16,250 | -- | -- | 32% 50.0K to 66.25K | |
| 26-Oct-23 4:29 PM View: | Greenberg Eric Howard Director | Titan Pharmaceuticals Inc. (TTNP) | 25-Oct-23 | Grant | 16,250 | -- | -- | 32% 50.0K to 66.25K | |
| 26-Oct-23 4:25 PM View: | Beebe Katherine President and COO Director | Titan Pharmaceuticals Inc. (TTNP) | 25-Oct-23 | Grant | 16,250 | -- | -- | 32% 50.0K to 66.25K | |
| 28-Jul-23 5:47 PM View: | Chasey Peter Louis Director | Titan Pharmaceuticals Inc. (TTNP) | 26-Jul-23 | Grant | 50,000 | -- | -- | 100% 0 to 50.0K | |
| 28-Jul-23 5:42 PM View: | Natan David Director | Titan Pharmaceuticals Inc. (TTNP) | 26-Jul-23 | Grant | 50,000 | -- | -- | 100% 0 to 50.0K | |
| 31-Jul-23 7:38 PM View: | Ben-Tzvi Avraham Director | Titan Pharmaceuticals Inc. (TTNP) | 26-Jul-23 | Grant | 50,000 | -- | -- | 100% 0 to 50.0K | |
| 31-Jul-23 8:06 PM View: | Greenberg Eric Howard Director | Titan Pharmaceuticals Inc. (TTNP) | 26-Jul-23 | Grant | 50,000 | -- | -- | 100% 0 to 50.0K | |
| 28-Jul-23 5:45 PM View: | Beebe Katherine President and COO Director | Titan Pharmaceuticals Inc. (TTNP) | 26-Jul-23 | Grant | 50,000 | -- | -- | 100% 0 to 50.0K | |
| 28-Jul-23 5:43 PM View: | McMurdo Matthew Charles Director | Titan Pharmaceuticals Inc. (TTNP) | 26-Jul-23 | Grant | 50,000 | -- | -- | 100% 0 to 50.0K | |
| 31-Jul-23 7:39 PM View: | Lazar David E. Chief Executive Officer Director | Titan Pharmaceuticals Inc. (TTNP) | 26-Jul-23 | Grant | 100,000 | -- | -- | 100% 0 to 100.0K | |
| 23-Jun-23 4:07 PM View: | Lazar David E. Chief Executive Officer Director 10% Owner | Titan Pharmaceuticals Inc. (TTNP) | 21-Jun-23 | Private Sale | 3,388,900 | $1.23 | $4,168,350.00 | (90%) 3.75M to 359.07K | |
| 23-Jun-23 4:07 PM View: | Lazar David E. Chief Executive Officer Director 10% Owner | Titan Pharmaceuticals Inc. (TTNP) | 21-Jun-23 | Sale | 359,066 | $1.23 | $441,651.00 | (100%) 359.07K to 0 | |
| 26-Jan-23 1:05 PM View: | Lazar David E. Chief Executive Officer Director 10% Owner | Titan Pharmaceuticals Inc. (TTNP) | 25-Jan-23 | Market Purchase | 20,000 | $1.00 | $20,066.00 | < 1% 3.73M to 3.75M | (< 1%) |
| 26-Jan-23 1:05 PM View: | Lazar David E. Chief Executive Officer Director 10% Owner | Titan Pharmaceuticals Inc. (TTNP) | 24-Jan-23 | Market Purchase | 37,500 | $0.97 | $36,221.20 | 1% 3.69M to 3.73M | 4% |
| 08-Jul-22 6:00 PM View: | Lazar David E. 10% Owner | Titan Pharmaceuticals Inc. (TTNP) | 07-Jul-22 | Purchase | 744,294 | $0.99 | $739,010.00 | 25% 2.95M to 3.69M | |
| 08-Jul-22 6:00 PM View: | Lazar David E. 10% Owner | Titan Pharmaceuticals Inc. (TTNP) | 06-Jul-22 | Private Purchase | 1,165,980 | $0.77 | $901,882.00 | 80% 1.46M to 2.63M | |
| 08-Jul-22 6:00 PM View: | Lazar David E. 10% Owner | Titan Pharmaceuticals Inc. (TTNP) | 06-Jul-22 | Purchase | 315,921 | $0.89 | $281,991.00 | 12% 2.63M to 2.95M | |
| 28-Jan-22 3:14 PM View: | McNab James R Director | Titan Pharmaceuticals Inc. (TTNP) | 28-Jan-22 | Acquisition (other) | 51,021 | -- | -- | 3057% 1.67K to 52.69K | |
| 22-Oct-18 4:38 PM View: | Recli Federico Seghi Director | Titan Pharmaceuticals Inc. (TTNP) | 19-Oct-18 | Purchase | 200,000 | -- | -- | 33% 600.85K to 800.85K | |
| 26-Sep-18 5:45 PM View: | Recli Federico Seghi Director | Titan Pharmaceuticals Inc. (TTNP) | 24-Sep-18 | Purchase | 500,000 | -- | -- | 496% 100.84K to 600.85K | |
| 25-Sep-18 7:09 PM View: | MacFarlane M David Director | Titan Pharmaceuticals Inc. (TTNP) | 21-Sep-18 | Market Purchase | 80,000 | $0.25 | $20,000.00 | 359% 22.27K to 102.28K | |
| 25-Sep-18 7:06 PM View: | Bhonsle Sunil See Remarks Director | Titan Pharmaceuticals Inc. (TTNP) | 21-Sep-18 | Market Purchase | 300,000 | $0.25 | $75,000.00 | 158% 190.26K to 490.26K | |
| 25-Sep-18 7:02 PM View: | Rubin Marc Executive Chairman Director | Titan Pharmaceuticals Inc. (TTNP) | 21-Sep-18 | Market Purchase | 400,000 | $0.25 | $100,000.00 | 256% 156.32K to 556.32K | |
| 25-Sep-18 7:00 PM View: | Akers Joseph A Director | Titan Pharmaceuticals Inc. (TTNP) | 21-Sep-18 | Market Purchase | 200,000 | $0.25 | $50,000.00 | 1538% 13.0K to 213.0K | |
| 25-Sep-18 7:04 PM View: | McNab James R Director | Titan Pharmaceuticals Inc. (TTNP) | 21-Sep-18 | Market Purchase | 200,000 | $0.25 | $50,000.00 | 200% 100.0K to 300.0K | |
| 19-Jul-16 3:55 PM View: | Akers Joseph A Director | Titan Pharmaceuticals Inc. (TTNP) | 19-Jul-16 | Market Purchase | 5,000 | $4.68 | $23,400.00 | 62% 8.0K to 13.0K | (73%) |
| 19-Jul-16 3:50 PM View: | Bhonsle Sunil President and CEO Director | Titan Pharmaceuticals Inc. (TTNP) | 18-Jul-16 | Market Purchase | 10,000 | $4.95 | $49,550.00 | 6% 180.26K to 190.26K | |
| 19-Jul-16 3:55 PM View: | Akers Joseph A Director | Titan Pharmaceuticals Inc. (TTNP) | 18-Jul-16 | Market Purchase | 8,000 | $4.95 | $39,600.00 | 100% 0 to 8.0K | |
| 31-May-16 5:32 PM View: | McNab James R Director | Titan Pharmaceuticals Inc. (TTNP) | 31-May-16 | Market Purchase | 20,000 | $7.03 | $140,600.00 | 25% 80.0K to 100.0K | |
| 22-Feb-16 8:32 PM View: | Bhonsle Sunil President and CEO Director | Titan Pharmaceuticals Inc. (TTNP) | 22-Feb-16 | Market Purchase | 11,763 | $3.56 | $41,817.50 | 7% 168.5K to 180.26K | |
| 19-Jan-16 4:02 PM View: | Bhonsle Sunil President and CEO Director | Titan Pharmaceuticals Inc. (TTNP) | 15-Jan-16 | Market Purchase | 5,841 | $2.72 | $15,887.50 | 4% 162.66K to 168.5K | |
| 14-Jan-16 2:11 PM View: | McNab James R Director | Titan Pharmaceuticals Inc. (TTNP) | 13-Jan-16 | Market Purchase | 16,363 | $3.16 | $51,707.10 | 26% 63.64K to 80.0K | |
| 11-Jan-16 5:58 PM View: | Rubin Marc Executive Chairman Director | Titan Pharmaceuticals Inc. (TTNP) | 11-Jan-16 | Market Purchase | 5,000 | $3.25 | $16,250.00 | 3% 151.32K to 156.32K | |
| 11-Jan-16 5:57 PM View: | Bhonsle Sunil President and CEO Director | Titan Pharmaceuticals Inc. (TTNP) | 11-Jan-16 | Market Purchase | 17,000 | $3.18 | $54,060.00 | 12% 145.66K to 162.66K | |
| 01-Oct-15 4:55 PM View: | Bhonsle Sunil President Director | Titan Pharmaceuticals Inc. (TTNP) | 01-Oct-15 | Market Purchase | 200 | $3.99 | $798.00 | < 1% 145.46K to 145.66K | (69%) |
| 01-Oct-15 4:55 PM View: | Bhonsle Sunil President Director | Titan Pharmaceuticals Inc. (TTNP) | 30-Sep-15 | Market Purchase | 500 | $3.98 | $1,990.00 | < 1% 144.96K to 145.46K | (69%) |
| 29-Sep-15 9:36 PM View: | Bhonsle Sunil President Director | Titan Pharmaceuticals Inc. (TTNP) | 28-Sep-15 | Purchase | 910 | $3.62 | $3,296.02 | < 1% 144.05K to 144.96K | |
| 16-Sep-15 6:48 PM View: | Bhonsle Sunil President Director | Titan Pharmaceuticals Inc. (TTNP) | 16-Sep-15 | Market Purchase | 5,000 | $0.70 | $3,500.00 | < 1% 787.26K to 792.26K | (68%) |
| 16-Sep-15 6:48 PM View: | Bhonsle Sunil President Director | Titan Pharmaceuticals Inc. (TTNP) | 15-Sep-15 | Market Purchase | 5,000 | $0.69 | $3,450.00 | < 1% 782.26K to 787.26K | (67%) |
| 31-Aug-15 5:19 PM View: | Rubin Marc Executive Chairman Director | Titan Pharmaceuticals Inc. (TTNP) | 28-Aug-15 | Market Purchase | 50,000 | $0.71 | $35,750.00 | 6% 782.2K to 832.2K | (69%) |
| 26-Aug-15 2:24 PM View: | Bhonsle Sunil President Director | Titan Pharmaceuticals Inc. (TTNP) | 25-Aug-15 | Market Purchase | 50,000 | $0.70 | $34,800.00 | 7% 732.26K to 782.26K | (67%) |
| 14-Oct-14 12:09 PM View: | Bhonsle Sunil President Director | Titan Pharmaceuticals Inc. (TTNP) | 13-Oct-14 | Market Purchase | 92,000 | $0.47 | $43,240.00 | 16% 565.26K to 657.26K | (53%) |
| 14-Oct-14 12:09 PM View: | Bhonsle Sunil President Director | Titan Pharmaceuticals Inc. (TTNP) | 10-Oct-14 | Market Purchase | 24,000 | $0.49 | $11,688.00 | 9% 276.76K to 300.76K | (54%) |
| 14-Oct-14 12:13 PM View: | Rubin Marc Executive Chairman Director | Titan Pharmaceuticals Inc. (TTNP) | 09-Oct-14 | Market Purchase | 100,000 | $0.48 | $48,200.00 | 16% 607.2K to 707.2K | (54%) |
| 14-Oct-14 12:09 PM View: | Bhonsle Sunil President Director | Titan Pharmaceuticals Inc. (TTNP) | 09-Oct-14 | Market Purchase | 100,000 | $0.48 | $47,800.00 | 50% 200.76K to 300.76K | (53%) |
| 14-Feb-14 4:57 PM View: | Rubin Marc Executive Chairman Director 10% Owner | Titan Pharmaceuticals Inc. (TTNP) | 12-Feb-14 | Grant | 100,000 | $0.66 | $66,000.00 | 17% 582.2K to 682.2K | (66%) |
| 14-Feb-14 4:59 PM View: | Bhonsle Sunil President Director | Titan Pharmaceuticals Inc. (TTNP) | 12-Feb-14 | Grant | 100,000 | $0.66 | $66,000.00 | 24% 416.26K to 516.26K | (66%) |
